Search - tctmd.com

Displaying 481 - 500 of 575

Sort: Relevancy | Date

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

La PCI Radial + Bivalirudina es Eficaz Minimizando el Riesgo Hemorrágico

L.A. McKeown

August 19, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

Yael L. Maxwell

August 09, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

La Revascularización Incompleta No Dificulta la TAVR en el Tratamiento de la Estenosis Aórtica Severa

Caitlin E. Cox

July 19, 2013

News Daily News

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Caitlin E. Cox

July 19, 2013

News Daily News

Un Modelo de Riesgo Predice las Readmisiones Hospitalarias post-PCI a los 30 Días

Jason Kahn

July 12, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

Presentation Transradial 2013

Ad Hoc PCI via the Transradial Approach: How to Achieve Success

Presenter: Ajay J. Kirtane

June 28, 2013

News Daily News

Un Registro Japonés No halla Beneficio alguno sobre la Mortalidad con PCI de OTC aún cuando las PCI tienen Éxito

Caitlin E. Cox

June 20, 2013

News Daily News

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

Presenter: Fabian Nietlispach

June 13, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

News Daily News

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

Jason Kahn

April 12, 2013

News Daily News

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Jason Kahn

April 12, 2013

Advertisement

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

La PCI Radial + Bivalirudina es Eficaz Minimizando el Riesgo Hemorrágico

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

La Revascularización Incompleta No Dificulta la TAVR en el Tratamiento de la Estenosis Aórtica Severa

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Un Modelo de Riesgo Predice las Readmisiones Hospitalarias post-PCI a los 30 Días

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

Ad Hoc PCI via the Transradial Approach: How to Achieve Success

Un Registro Japonés No halla Beneficio alguno sobre la Mortalidad con PCI de OTC aún cuando las PCI tienen Éxito

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Ad-hoc TAVI, Ad-hoc Coronary Stenting, and Ad-hoc LAA Closure

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Ischemia-Based Treatment Does Not Alter Mortality in Postrevascularization Patients

El Tratamiento basado en la Isquemia No Altera la Mortalidad en Pacientes Postrevascularizados

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content